T1	Concept 198 202	S416
T2	Concept 234 242	chemical
T3	Concept 219 233	best efficient
R1	is-a Arg1:T1 Arg2:T2	
R2	has-property Arg1:T1 Arg2:T3	
T4	Concept 276 290	cellular level
T5	Concept 306 316	SARS virus
T6	Concept 479 489	SARS-CoV-2
T7	Concept 243 249	so far
R3	in-time Arg1:T3 Arg2:T7	
T8	Concept 258 268	SARS-CoV-2
R4	in-context Arg1:T3 Arg2:T8	
T9	Concept 356 363	studies
T10	Concept 337 355	structural biology
T11	Concept 318 332	viral genomics
R5	in-context Arg1:T9 Arg2:T10	
R6	in-context Arg1:T9 Arg2:T11	
T12	Concept 380 384	ACE2
T13	Concept 395 414	functional receptor
R7	is-a Arg1:T12 Arg2:T13	
T14	Concept 427 437	SARS-CoV-2
T15	Concept 438 449	coronavirus
R8	is-a Arg1:T14 Arg2:T15	
R9	in-context Arg1:T13 Arg2:T14	
R10	causes Arg1:T9 Arg2:T12	
T16	Concept 423 426	new
R11	has-property Arg1:T14 Arg2:T16	
T17	Concept 525 563	angiotensin converting enzyme 2 (ACE2)
T18	Concept 504 523	cell entry receptor
R12	is-a Arg1:T17 Arg2:T18	
T19	Concept 459 464	study
T20	Concept 581 589	SARS-CoV
T21	Action 495 499	uses
R13	subject Arg1:T21 Arg2:T6	
R14	target Arg1:T21 Arg2:T17	
T22	Concept 570 577	similar
R15	has-property Arg1:T21 Arg2:T22	
R16	in-context Arg1:T22 Arg2:T20	
T23	Concept 154 174	SARS-CoV-2 infection
T24	Concept 178 191	Vero E6 cells
T25	Concept 137 146	procedure
R17	in-context Arg1:T25 Arg2:T23	
R18	in-place Arg1:T25 Arg2:T24	
T26	Concept 95 115	antiviral activities
A1	Emphasized T26
R19	in-time Arg1:T26 Arg2:T25	
T27	Concept 70 80	remdesivir
T28	Concept 59 65	CVL218
T29	Concept 34 52	DMSO control group
R20	in-context Arg1:T28 Arg2:T29	
R21	in-context Arg1:T27 Arg2:T29	
R22	causes Arg1:T19 Arg2:T6	
R23	causes Arg1:T28 Arg2:T26	
R24	causes Arg1:T27 Arg2:T26	
T30	Concept 607 619	transmission
T31	Concept 590 606	Hospital-related
R25	in-context Arg1:T30 Arg2:T31	
T32	Concept 646 655	infection
T33	Concept 659 678	health-care workers
R26	causes Arg1:T30 Arg2:T32	
R27	in-context Arg1:T32 Arg2:T33	
T34	Concept 715 732	COVID-19 epidemic
T35	Concept 801 811	SARS-CoV-2
T36	Concept 864 884	protective materials
T39	Concept 758 767	knowledge
A2	Diminished T39
T40	Concept 852 860	shortage
R30	in-context Arg1:T40 Arg2:T36	
R31	in-time Arg1:T32 Arg2:T40	
T41	Concept 774 797	transmission approaches
R32	in-context Arg1:T41 Arg2:T35	
R33	in-context Arg1:T39 Arg2:T41	
T37	Concept 699 711	early stages
R28	in-context Arg1:T37 Arg2:T34	
R29	in-time Arg1:T37 Arg2:T39	
R34	in-time Arg1:T32 Arg2:T37	
T38	Reference 565 566	4
T42	Reference 568 569	5
R35	in-context Arg1:T38 Arg2:T17	
R36	in-context Arg1:T42 Arg2:T17	
